Skip to main content

Table 1 Baseline

From: Mid-term results of mitral valve repair using flexible bands versus complete rings in patients with degenerative mitral valve disease: a prospective, randomized study

  SR Group,
n = 85
FB Group,
n = 86
Р value
FED, n (%) 65 (76.5) 56 (65.1) 0.103
Forme fruste, n (%) 12 (14.1) 18 (20.9) 0.241
Barlow, n (%) 8 (9.4) 12 (14.0) 0.355
Male, n (%) 59 (69.4) 58 (67.4) 0.782
Age, years 57 (23–75) 54 (19–74) 0.092
Height, cm 173 (148–192) 175 (151;193) 0.079
Weight, kg 79.1 ± 14.6 77.1 ± 16.4 0.388
BMI, kg/m2 26.9 ± 4.3 25.4 ± 4.6 0.522
BSA, m2 1.94 ± 0.21 1.93 ± 0.24 0.801
NYHA I, n (%) 7 (8.2) 12 (14.0) 0.234
NYHA II, n (%) 22 (25.9) 29 (33.7) 0.263
NYHA III, n (%) 54 (63.5) 43 (50.0) 0.742
NYHA IV, n (%) 2 (2.4) 2 (2.3) 0.991
AF, n (%) 22 (25.9) 16 (18.6) 0.252
Paroxysmal, n (%) 2 (2.4) 2 (2.3) 0.991
Persistent, n (%) 5 (5.9) 3 (3.5) 0.459
Long-standing, n (%) 11 (12.9) 9 (10.5) 0.614
Permanent, n (%) 4 (4.7) 2 (2.3) 0.398
CAD, n (%) 10 (11.8) 4 (4.7) 0.090
Arterial hypertension, n (%) 46 (54.1) 42 (48.8) 0.490
Diabetes mellitus, n (%) 4 (4.7) 5 (5.8) 0.746
Moderate renal impairment, n (%) 1 (1.2) 1 (1.2) 0.993
Peripheral vascular disease, n (%) 5 (5.9) 3 (3.5) 0.459
Cerebrovascular disease, n (%) 5 (5.9) 4 (4.7) 0.719
LV EF, % 65.5 (49–80) 67.0 (51–89) 0.212
PA pressure, mm Hg 48.5 (29–80) 45.0 (29–94) 0.053
  1. SR semirigid ring, FB flexible band, BMI body mass index, BSA body surface area, NYHA New York Heart Association functional class, AF atrial fibrillation, CAD coronary artery disease, LV EF left ventricle ejection fraction, PA pulmonary artery